These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15064482)

  • 1. Assessment of predictive values of tumor markers.
    Roulston JE
    Methods Mol Med; 2004; 97():13-27. PubMed ID: 15064482
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality assurance of predictive markers in breast cancer.
    Rhodes A; Barnes DM
    Methods Mol Med; 2004; 97():29-57. PubMed ID: 15064483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Criteria for the use of tumor markers. 1: Quality assurance--characteristics of the most important tumor markers].
    Fateh-Moghadam A; Stieber P
    Fortschr Med; 1996 Feb; 114(6):30-3. PubMed ID: 8900526
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumour markers.
    Pandha HS; Waxman J; Sikora K
    Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):297-303. PubMed ID: 8032568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Criteria for using tumor markers. 2: Indications and interpretation].
    Fateh-Moghadam VA; Stieber P
    Fortschr Med; 1996 Mar; 114(7):38-40. PubMed ID: 8900968
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic sensitivity and specificity and positive predictive value in the mass screening for cancer].
    Ohkawa J
    Rinsho Byori; 1988 Jul; 36(7):781-6. PubMed ID: 3236460
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumor markers: theory or reality?].
    Molina R; Filella X; Ballesta AM
    Med Clin (Barc); 1994 Feb; 102(5):189-95. PubMed ID: 8127170
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumor markers--how they should be applied].
    Stieber P; Heinemann V; Schalhorn A
    MMW Fortschr Med; 2005 May; 147(20):35, 37-9. PubMed ID: 15957858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is an improved PSA screening test in sight?
    Savage L
    J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
    [No Abstract]   [Full Text] [Related]  

  • 10. Back to the drawing board on immunohistochemistry and predictive factors.
    Henson DE
    J Natl Cancer Inst; 2005 Dec; 97(24):1796-7. PubMed ID: 16368935
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of test positive predictive value in ovarian cancer screening.
    Greene MH; Feng Z; Gail MH
    Clin Cancer Res; 2008 Nov; 14(22):7574; author reply 7577-9. PubMed ID: 18948386
    [No Abstract]   [Full Text] [Related]  

  • 12. [How reliable are tumor markers? Only the experienced physician knows how to apply these diagnostic aids sensibly].
    Janssen K
    Fortschr Med; 1995 Feb; 113(4):49-51. PubMed ID: 7713468
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunohistochemical studies].
    Dietz A; Bosch F
    HNO; 2004 May; 52(5):468-70. PubMed ID: 15088091
    [No Abstract]   [Full Text] [Related]  

  • 14. Risks of online direct-to-consumer tumor markers for cancer screening.
    Lovett KM; Liang BA; Mackey TK
    J Clin Oncol; 2012 May; 30(13):1411-4. PubMed ID: 22355060
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of generalizability of sensitivity and specificity with treatment effects.
    Dodd LE; Korn EL
    Stat Med; 2008 May; 27(10):1734-44. PubMed ID: 17940996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for oesophageal cancer: is it timely or premature?
    Baer HJ; Colditz GA
    J Med Screen; 2005; 12(3):109-11. PubMed ID: 16156938
    [No Abstract]   [Full Text] [Related]  

  • 17. [When to use Ki67].
    Scoazec JY
    Ann Pathol; 2011 Nov; 31(5 Suppl):S52-4. PubMed ID: 22054460
    [No Abstract]   [Full Text] [Related]  

  • 18. Biomarkers and histology of premalignant and malignant lesions.
    Beltrami AC; Puglisi F; Di Lauro V; Scalone S; Amoroso V; Bonura S; Stamerra O; Raiti C; Di Loreto C
    Eur J Cancer Prev; 1996 Oct; 5(5):375-6. PubMed ID: 8972261
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomarker boom slowed by validation concerns.
    Benowitz S
    J Natl Cancer Inst; 2004 Sep; 96(18):1356-7. PubMed ID: 15367567
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increased carcinoembryonic antigen level: which diagnosis?].
    Gärtner H; Maier KP
    Dtsch Med Wochenschr; 2005 Feb; 130(7):353. PubMed ID: 15756728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.